

Inhaled pharmaceutical products maker Vectura said trading has been in line with expectations for the period from 1 April to 21 July, lifting investor...


Is there something to Yell about at last for yet another business struggling to cope with the impact of the internet revolution? asks the Independent....


Yesterday, the logistics group Stobart issued full-year figures, with pre-tax profits falling short of market hopes. But the share price rose as the f...


Vectura, the respiratory inhaler firm, reduced losses for the year, drove revenues higher and said it is on track for annual cost-savings of approxima...


It was downhill almost all the way for Footsie in the afternoon session after the US opened sharply lower, with miners getting a real bashing on the p...


Respiratory inhaler developer Vectura is among the stocks lifting the pharmaceutical sector after positive data from a Phase II clinical study of a tr...


Footsie retreated further over the lunch time session with mining stocks largely responsible for the decline, as metal prices pull back on fears that ...


Shares in Vectura moved higher after the respiratory inhaler developer announced higher revenues, sharply narrower losses and positive data from a Pha...